All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
ZYME / Zymeworks Inc.
|
|
|
|
|
|
|
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
|
|
|
|
|
NGM / NGM Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
EQ / Equillium, Inc.
|
|
|
|
|
|
|
|
ODT / Odonate Therapeutics Inc
|
|
|
|
|
|
|
|
IOBT / IO Biotech, Inc.
|
|
|
|
|
|
|
|
KRON / Kronos Bio, Inc.
|
|
|
|
|
|
|
|
ELEV / Elevation Oncology, Inc.
|
|
|
|
|
|
|
|
BLSA / BCLS Acquisition Corp - Class A
|
|
|
|
|
|
|
|
JYAC / Jiya Acquisition Corp - Class A
|
|
|
|
|
|
|
|
SRZN / Surrozen, Inc.
|
|
|
|
|
|
|
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
RXRX / Recursion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
US03217L1061 / Amryt Pharma PLC Sponsored ADR (United Kingdom)
|
|
|
|
|
|
|
|
VTGN / Vistagen Therapeutics, Inc.
|
|
|
|
|
|
|
|
ATXS / Astria Therapeutics, Inc.
|
|
|
|
|
|
|
|
DBTX / Decibel Therapeutics Inc
|
|
|
|
|
|
|
|
ALLK / Allakos Inc. Call
|
|
|
|
|
|
|
|
TERN / Terns Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
|
|
|
|
|
|
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ALXO / ALX Oncology Holdings Inc.
|
|
|
|
|
|
|
|
VTVT / vTv Therapeutics Inc.
|
|
|
|
|
|
|
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
|
|
|
|
|
ACLX / Arcellx, Inc.
|
|
|
|
|
|
|
|
ALBO / Albireo Pharma Inc
|
|
|
|
|
|
|
|
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ICPT / Intercept Pharmaceuticals Inc
|
|
|
|
|
|
|
|
FMTX / Forma Therapeutics Holdings Inc
|
|
|
|
|
|
|
|
BCEL / Atreca, Inc.
|
|
|
|
|
|
|
|
ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
GRPH / Graphite Bio, Inc.
|
|
|
|
|
|
|
|
DICE / DICE Therapeutics Inc
|
|
|
|
|
|
|
|
IGMS / IGM Biosciences, Inc.
|
|
|
|
|
|
|
|
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
AGLE / Aeglea BioTherapeutics Inc
|
|
|
|
|
|
|
|
TIL / Instil Bio, Inc.
|
|
|
|
|
|
|
|
SYRS / Syros Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
KALA / KALA BIO, Inc.
|
|
|
|
|
|
|
|
NVAX / Novavax, Inc.
|
|
|
|
|
|
|
|
NVAX / Novavax, Inc. Call
|
|
|
|
|
|
|
|
EYPT / EyePoint Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
KDNY / Chinook Therapeutics Inc
|
|
|
|
|
|
|
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
|
|
|
|
|
|
NKTX / Nkarta, Inc.
|
|
|
|
|
|
|
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
SRRK / Scholar Rock Holding Corporation
|
|
|
|
|
|
|
|
ALVR / AlloVir, Inc.
|
|
|
|
|
|
|
|
DAWN / Day One Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
JANX / Janux Therapeutics, Inc.
|
|
|
|
|
|
|
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
TNGX / Tango Therapeutics, Inc.
|
|
|
|
|
|
|
|
STRO / Sutro Biopharma, Inc.
|
|
|
|
|
|
|
|
ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
BOLT / Bolt Biotherapeutics, Inc.
|
|
|
|
|
|
|
|